GGrantIndex
← Search

PRECLINICAL DEVELOPMENT OF TUMOR-SPECIFIC HSP 70 INHIBITORS IN BREAST CANCER

$322,913FY2010Department of the ArmyDOD

Sloan-Kettering Institute For Cancer Research

Investigators

View source on USAspending →
PRECLINICAL DEVELOPMENT OF TUMOR-SPECIFIC HSP 70 INHIBITORS IN BREAST CANCER · GrantIndex